Help Arthritis With Exercise in West Virginia (HARE)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by Centers for Disease Control and Prevention.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
West Virginia University
Information provided by:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00526201
First received: September 6, 2007
Last updated: April 20, 2010
Last verified: April 2010
  Purpose

The purpose of this project is to determine if an evidence-based, community-delivered physical activity program, EnhanceFitness, yields benefits for participants with arthritis. The 3-year project will: 1) conduct a meta-analysis of community-based exercise programs for adults, 2) implement and evaluate the EnhanceFitness program in West Virginia using a randomized, controlled (wait list) design, and 3) disseminate the results to community and public health partners. It is anticipated that participation in the EnhanceFitness program will result in reduced pain, improved physical function and physical activity levels for adults with arthritis.


Condition Intervention Phase
Arthritis
Behavioral: 12-weeks EnhanceFitness
Behavioral: Control
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Arthritis Benefits of a Physical Activity Program in West Virginia: Evaluation of EnhanceFitness

Resource links provided by NLM:


Further study details as provided by Centers for Disease Control and Prevention:

Primary Outcome Measures:
  • Pain Severity [ Time Frame: 8 months ] [ Designated as safety issue: No ]
  • Physical activity level [ Time Frame: 8 months ] [ Designated as safety issue: No ]
  • Physical Function [ Time Frame: 8 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Health-related quality of life [ Time Frame: 8 months ] [ Designated as safety issue: No ]
  • Arthritis self-efficacy [ Time Frame: 8 months ] [ Designated as safety issue: Yes ]
  • Self-efficacy for exercise [ Time Frame: 8 months ] [ Designated as safety issue: No ]
  • Exercise perceptions [ Time Frame: 8 months ] [ Designated as safety issue: No ]
  • Social support [ Time Frame: 8 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 375
Study Start Date: May 2008
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Exercise
Subjects will be randomized to exercise (12 week EnhanceFitness class) or a wait-list control group.
Behavioral: 12-weeks EnhanceFitness
EnhanceFitness class for 12 weeks, 3 times per week for 1 hour sessions.
No Intervention: Control
Wait-list control group will receive intervention after 12-weeks.
Behavioral: Control
Participants randomized to the wait-list control group will continue their regular activities for 12 weeks and then be offered the exercise intervention (EnhanceFitness).

  Eligibility

Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age 18 and older
  • Any type of self-reported, doctor-diagnosed arthritis

Exclusion Criteria:

  • Any co-existing conditions where exercise is a contraindicated
  • Impaired cognitive status
  • Non-ambulatory
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00526201

Locations
United States, West Virginia
West Virginia University
Morgantown, West Virginia, United States, 26506-9196
Sponsors and Collaborators
West Virginia University
Investigators
Principal Investigator: Dina L Jones, PT, PHD West Virginia University
Study Director: Jennifer M Hootman, PhD Centers for Disease Control and Prevention
  More Information

No publications provided

Responsible Party: Dina L. Jones PT, PHD, West Virginia University
ClinicalTrials.gov Identifier: NCT00526201     History of Changes
Other Study ID Numbers: CDC-NCCDPHP-AAMC-0944, AAMC-0944
Study First Received: September 6, 2007
Last Updated: April 20, 2010
Health Authority: United States: Federal Government

Keywords provided by Centers for Disease Control and Prevention:
Arthritis
Osteoarthritis
Rheumatoid Arthritis
Fibromyalgia
Lupus

Additional relevant MeSH terms:
Arthritis
Joint Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on October 21, 2014